Прегледање према Аутор Goločorbin-Kon, Svetlana
Приказивање резултата 11 do 30 od 68
< претходна
следећа >
Датум издавања | Наслов | Аутор(и) |
---|---|---|
1-јан-2009 | Cefotaxime pharmacokinetics after oral application in the form of 3α,7α-dihydroxy-12-keto-5β-cholanate microvesicles in rat | Svetlana Goločorbin-Kon ; Momir Mikov ; Arafat M.; Žika Lepojević; Ivan Mikov ; Sahman-Zaimovic M.; Zdenko Tomić |
1-јан-2011 | Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations | Mladena Lalić-Popović ; Ana Pilipović ; Svetlana Goločorbin-Kon ; Ksenija Gebauer Bukurov ; Ksenija Božić; Momir Mikov ; Jelena Helen Hogervorst |
1-јан-2014 | Current experience and future perspectives of bromelain application in medicine | Nataša Milić ; Maja Milanović ; Svetlana Goločorbin-Kon ; Nataša Milošević |
1-мар-2016 | Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes | Mladena Lalić-Popović ; Jovana Paunković; Zorica Grujić ; Svetlana Goločorbin-Kon ; Ljubomir Milašinović; Hani Al-Salami; Momir Mikov |
1-јул-2013 | Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat | Mladena Lalić-Popović ; Velibor Vasović ; Boris Milijašević ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Momir Mikov |
17-окт-2013 | Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women | Mladena Lalić-Popović ; Jovana Paunković; Zorica Grujić ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Momir Mikov |
30-авг-2017 | Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects | Sangeetha Mathavan; Momir Mikov ; Svetlana Goločorbin-Kon ; Hani Al-Salami |
1-јан-2016 | Docking-based preliminary study on the interactions of bile acids with drugs at the transporter level in intestinal bacteria | Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Tijana Ostojić ; Svetlana Goločorbin-Kon ; Gordana Smieško ; Momir Mikov |
феб-2020 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Momir Mikov ; Nebojša Pavlović ; Bojan Stanimirov ; Maja Đanić ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
1-јан-2019 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Mikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H. |
1-дец-2018 | Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring | Svetlana Goločorbin-Kon ; Momir Mikov ; Jelena Helen Hogervorst ; Hani Al-Salami; Vladimir Maksimović |
1-дец-2016 | The Effect of Diabetes and Hypertension on the Placental Permeation of the Hydrophilic Drug, Ranitidine | Mladena Lalić-Popović ; Jovana Paunković; Zorica Grujić ; Svetlana Goločorbin-Kon ; Velibor Vasović ; Hani Al-Salami; Momir Mikov |
1-јан-2012 | Effect of simultaneous exposure to benzene and ethanol on urinary thioether excretion | Ivan Mikov ; Karmen Stankov ; Velibor Vasović ; Aleksandra Mikov ; Svetlana Goločorbin-Kon ; Momir Mikov |
1-нов-2018 | Eudragit-based microcapsules of probucol with a gut-bacterial processed secondary bile acid | Armin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Hani Al-Salami |
23-авг-2018 | Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid | Mooranian, A.; Zamani, N.; Momir Mikov ; Svetlana Goločorbin-Kon ; Stojanović, Goran ; Arfuso, F.; Al-Salami, H. |
15-нов-2016 | Evaluation of Dried Blood Spot technology in preclinical and clinical development | Elodie Mauchauffée; Cedric Poinsard; Emilie Borde; Momir Mikov ; Svetlana Goločorbin-Kon ; Dragan Spasić |
1-јан-2019 | Formulation buoyancy of nanoencapsulated gliclazide using primary, conjugated and deconjugated bile acids | Mathavan S.; Ionescu C.; Božica Kovačević; Momir Mikov ; Svetlana Goločorbin-Kon ; Mooranian A.; Dass C.; Al-Salami H. |
1-дец-2017 | High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect | Svetlana Goločorbin-Kon ; Jelena Calasan; Boris Milijašević ; Saša Vukmirović ; Mladena Lalić-Popović ; Momir Mikov ; Hani Al-Salami |
2019 | In silico alternatives to animal testing: state of the art | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Maja Đanić ; Bojan Stanimirov ; Mladena Lalić-Popović ; Momir Mikov |
1-јан-2019 | In silico discovery of resveratrol analogues as potential agents in treatment of metabolic disorders | Nebojša Pavlović ; Maja Đanić ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Mladena Lalić-Popović ; Momir Mikov |